Metabolic diseases The degradation of valine is impaired in the following
metabolic diseases: •
Combined malonic and methylmalonic aciduria (CMAMMA) •
Maple syrup urine disease (MSUD) •
Methylmalonic acidemia •
Propionic acidemia Insulin resistance Lower levels of serum valine, like other branched-chain amino acids, are associated with weight loss and decreased
insulin resistance: higher levels of valine are observed in the blood of diabetic mice, rats, and humans. Mice fed a BCAA-deprived diet for one day had improved insulin sensitivity, and feeding of a valine-deprived diet for one week significantly decreases blood glucose levels. In diet-induced obese and insulin resistant mice, a diet with decreased levels of valine and the other branched-chain amino acids resulted in a rapid reversal of the adiposity and an improvement in glucose-level control. The valine catabolite
3-hydroxyisobutyrate promotes insulin resistance in mice by stimulating fatty acid uptake into muscle and lipid accumulation. In mice, a BCAA-restricted diet decreased fasting blood glucose levels and improved body composition.
Hematopoietic stem cells Dietary valine is essential for
hematopoietic stem cell (HSC) self-renewal, as demonstrated by experiments in mice. Dietary valine restriction selectively depletes long-term repopulating HSC in mouse bone marrow. Successful stem cell transplantation was achieved in mice without irradiation after 3 weeks on a valine restricted diet. Long-term survival of the transplanted mice was achieved when valine was returned to the diet gradually over a 2-week period to avoid
refeeding syndrome. == See also ==